{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:53:56Z","timestamp":1791586436343,"version":"4.3.4"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T00:00:00Z","timestamp":1635206400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1097\/cm9.0000000000001827","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T03:14:27Z","timestamp":1635477267000},"page":"2844-2846","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":13,"title":["Caroli disease: an update on pathogenesis"],"prefix":"10.1097","volume":"134","author":[{"given":"Wen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai-Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,12,5]]},"reference":[{"key":"R1-20250603","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/hpb.12330","article-title":"Clinical classification of Caroli's disease: an analysis of 30 patients","volume":"17","author":"Wang","year":"2015","journal-title":"HPB (Oxford)"},{"key":"R2-20250603","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1751-2980.2012.00619.x","article-title":"Caroli's disease: a report of 14 patients and review of the literature","volume":"13","author":"Zhang","year":"2012","journal-title":"J Dig Dis"},{"key":"R3-20250603","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.md.0000200165.90373.9a","article-title":"Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD)","volume":"85","author":"Adeva","year":"2006","journal-title":"Medicine (Baltimore)"},{"key":"R4-20250603","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/hep.22636","article-title":"The cAMP effectors Epac and protein kinase a (PKA) are involved in the hepatic cystogenesis of an animal model of autosomal recessive polycystic kidney disease (ARPKD)","volume":"49","author":"Banales","year":"2009","journal-title":"Hepatology (Baltimore, MD)"},{"key":"R5-20250603","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0002-9440(10)62231-6","article-title":"Activation of the MEK5\/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's disease","volume":"166","author":"Sato","year":"2005","journal-title":"Am J Pathol"},{"key":"R6-20250603","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.ajpath.2018.06.014","article-title":"Blockade of Hedgehog signaling attenuates biliary cystogenesis in the polycystic kidney (PCK) rat","volume":"188","author":"Sato","year":"2018","journal-title":"Am J Pathol"},{"key":"R7-20250603","doi-asserted-by":"crossref","first-page":"e87660","DOI":"10.1371\/journal.pone.0087660","article-title":"Activation of the PI3K\/mTOR pathway is involved in cystic proliferation of cholangiocytes of the PCK rat","volume":"9","author":"Ren","year":"2014","journal-title":"PLoS One"},{"key":"R8-20250603","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jhep.2019.02.024","article-title":"Loss of fibrocystin promotes interleukin-8-dependent proliferation and CTGF production of biliary epithelium","volume":"71","author":"Tsunoda","year":"2019","journal-title":"J Hepatol"},{"key":"R9-20250603","doi-asserted-by":"crossref","first-page":"e81480","DOI":"10.1371\/journal.pone.0081480","article-title":"Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease","volume":"8","author":"Yoshihara","year":"2013","journal-title":"PloS One"},{"key":"R10-20250603","doi-asserted-by":"crossref","first-page":"F465","DOI":"10.1152\/ajprenal.00460.2010","article-title":"PPAR-gamma agonist ameliorates kidney and liver disease in an orthologous rat model of human autosomal recessive polycystic kidney disease","volume":"300","author":"Yoshihara","year":"2011","journal-title":"Am J Physiol Renal Physiol"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001827","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T19:09:20Z","timestamp":1748977760000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000001827"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,26]]},"references-count":10,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000001827","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,26]]}}}